Consolidated Basic Cancer Research Program
Consolidated Basic Cancer Research Program
批准号:
8894146
负责人:
Dario C Altieri
金额:
$9.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 2019-02-28
关键词:
AgreementAreaBasic Cancer ResearchBudgetsCancer BiologyCancer CenterCancer Research ProjectCollaborationsDecision MakingDevelopmentEducationEnvironmentFacultyFundingGrowthHealth systemMalignant NeoplasmsMalignant neoplasm of ovaryMentorsMissionNational Cancer InstitutePatientsProcessPublicationsRecruitment ActivityResearchResearch InfrastructureResource SharingScheduleScientistSpecimenStrategic PlanningThe Wistar InstituteTrainingVisionanticancer researchbasecancer research center directorcareer developmentmelanomamembermultidisciplinarynext generationpatient orientedprogramstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Wistar Institute Cancer Center has undergone transformative changes during the last budget period that reconfigured every administrative, scientific and educational segment of the organization. Coinciding with the recruitment of Dr. Altieri as the first, dedicated Director of the Cancer Center, an inclusive, transparent and highly
consultative strategic planning process was completed in the last budget period. Emerging from the 2012 Cancer Center Strategic Plan was a unifying vision to conquer cancer through outstanding research, education and partnership and an underlying mission to merge basic, translational and patient-oriented cancer research in a single scientific continuum. The stepwise but decisive implementation of the new strategic directives during the last budget period established a new administrative and decision-making infrastructure of the Cancer Center, comprehensively realigned scientific Programs for optimal research impact and synergistic collaboration, and reorganized Shared Resources as financially-sustainable engines of Wistar discoveries. To enable the vision of the Cancer Center in translational and patient-oriented cancer research, multidisciplinary, inter-programmatic initiatives were launched in the areas of melanoma and ovarian cancer, and unique inter-institutional agreements were established with regional health systems for access to clinically-annotated, primary patient specimens. Training the next generation of cancer scientists became a strategic priority, fulfilled with the launch of new, Wistar-based graduate program in cancer biology and the deployment of expansive mentoring and career development tools for junior faculty. Against this backdrop, the Cancer Center successfully recruited nine new faculty members at all academic ranks, many of them research leaders, during the last budget cycle, grew its National Cancer Institute (NCI) funding base by 21% from $8.1 million in 2008 to $10.2 million in 2013, and expanded its collaborative publications from an average of 9.7% in 2008 to 29.3% in 2013 across all three scientific Programs. The extraordinary growth of the past budget period, increased cancer focus, refinement of scientific themes and highly collaborative environment have now placed the Cancer Center on a steep upward trajectory, ideally suited to leverage the opening of a new, $102 million, seven story tall, Wistar Research Tower scheduled for the summer of 2014. Providing for the largest faculty and facility expansion of Wistar in forty years, the new Tower will enable the further development of focused and multidisciplinary flagship research themes in each Program along the continuum of basic, translational and patient-oriented cancer research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Augmenting T-cell immunotherapy outcomes in blood and solid tumor microenvironment in ART-suppressed HIV infection (immune/microenvironment)
-
批准号:10620011
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2022
-
负责人:Dario C Altieri
-
依托单位:
A First-in-Human Phase I Clinical Trial of Mitochondrial-Targeted Hsp90 Inhibitor, Gamitrinib
-
批准号:10472429
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2021
-
负责人:Dario C Altieri
-
依托单位:
A First-in-Human Phase I Clinical Trial of Mitochondrial-Targeted Hsp90 Inhibitor, Gamitrinib
-
批准号:9668658
-
项目类别:
-
资助金额:$41.03万
-
财政年份:2021
-
负责人:Dario C Altieri
-
依托单位:
Tumor Plasticity
-
批准号:10474434
-
项目类别:
-
资助金额:$111.72万
-
财政年份:2017
-
负责人:Dario C Altieri
-
依托单位:
Tumor Plasticity
-
批准号:10248385
-
项目类别:
-
资助金额:$114.0万
-
财政年份:2017
-
负责人:Dario C Altieri
-
依托单位:
Tumor Plasticity
-
批准号:9767084
-
项目类别:
-
资助金额:$110.42万
-
财政年份:2017
-
负责人:Dario C Altieri
-
依托单位:
Tumor Plasticity
-
批准号:10684678
-
项目类别:
-
资助金额:$111.72万
-
财政年份:2017
-
负责人:Dario C Altieri
-
依托单位:
Tumor Plasticity
-
批准号:9538612
-
项目类别:
-
资助金额:$114.0万
-
财政年份:2017
-
负责人:Dario C Altieri
-
依托单位:
Molecular and Cellular Oncogenesis
-
批准号:8690263
-
项目类别:
-
资助金额:$3.77万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Planning and Evaluation
-
批准号:8690274
-
项目类别:
-
资助金额:$3.53万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
(PQC2) Plasticity Of The.PI3K Network In Early Dormancy
-
批准号:8791730
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Genomics
-
批准号:8932921
-
项目类别:
-
资助金额:$21.48万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Bioinformatics Shared Resources
-
批准号:8690292
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Gene Expression
-
批准号:8689270
-
项目类别:
-
资助金额:$4.18万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Developmental Funds
-
批准号:8690275
-
项目类别:
-
资助金额:$44.68万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
IMAGING SHARED RESOURCE
-
批准号:8689269
-
项目类别:
-
资助金额:$7.59万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Proteomics Shared Resource
-
批准号:8932923
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Animal Facility Shared Resources
-
批准号:8690265
-
项目类别:
-
资助金额:$25.87万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Molecular Screening Shared Resource
-
批准号:8932922
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
(PQC2) Plasticity Of The.PI3K Network In Early Dormancy
-
批准号:9112948
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: